Competitors
| Companies | Market Cap | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|
|
Roche Holding SWX:ROG |
280,80 B | 1,38% | 6/6 | 3,15% | -14,21% | 8,11% | UP |
|
Merck NYSE:MRK |
286,28 B | 7,67% | 6/6 | -21,45% | -4,86% | 12,27% | UP |
|
Amgen NasdaqGS:AMGN |
199,20 B | 7,37% | 3/6 | 2,70% | -13,99% | -4,88% | UP |
|
Novo Nordisk A/S CPSE:NOVO B |
1.104,89 B | 20,54% | 5/6 | -8,48% | 65,56% | 24,27% | DOWN |
|
Pfizer NYSE:PFE |
153,81 B | 7,82% | 4/6 | -5,32% | 22,12% | -0,18% | UP |
|
Bristol-Myers Squibb NYSE:BMY |
122,78 B | 1,77% | 5/6 | -0,27% | -3,61% | 6,15% | UP |
|
Vertex Pharmaceuticals NasdaqGS:VRTX |
116,02 B | 13,44% | 6/6 | 6,44% | -6,33% | 19,99% | UP |
|
Sanofi ENXTPA:SAN |
93,86 B | 5,21% | 5/6 | 6,61% | 19,46% | 28,65% | DOWN |
|
Takeda Pharmaceutical Company TSE:4502 |
8.895,23 B | 10,31% | 4/6 | 21,60% | -28,21% | 1,23% | UP |
|
Bayer XTRA:BAYN |
37,18 B | -1,16% | 2/6 | -3,85% | 3,06% | 32,10% | UP |
|
Alnylam Pharmaceuticals NasdaqGS:ALNY |
42,53 B | 46,06% | 4/6 | 50,26% | 0,70% | 40,65% | DOWN |
|
Daiichi Sankyo Company TSE:4568 |
5.254,73 B | 17,16% | 4/6 | 9,31% | 63,60% | 72,29% | DOWN |
|
Biogen NasdaqGS:BIIB |
27,13 B | -10,57% | 1/6 | -1,11% | 8,47% | 11,70% | UP |
|
Moderna NasdaqGS:MRNA |
20,74 B | 12,29% | 2/6 | 18,96% | -632,82% | -26,69% | UP |
|
United Therapeutics NasdaqGS:UTHR |
20,96 B | 15,13% | 4/6 | 4,00% | -21,37% | 22,87% | UP |
|
Incyte NasdaqGS:INCY |
19,09 B | 41,79% | 6/6 | 9,03% | 26,54% | 14,65% | UP |
|
Hologic NasdaqGS:HOLX |
16,91 B | 2,80% | 5/6 | 3,50% | -6,67% | 0,34% | UP |
|
Viatris NasdaqGS:VTRS |
16,30 B | -3,69% | 3/6 | 4,90% | -50,74% | 5,93% | UP |
|
Swedish Orphan Biovitrum AB (publ) OM:SOBI |
131,77 B | 10,82% | 5/6 | 3,07% | -6,61% | 15,42% | UP |
|
Neurocrine Biosciences NasdaqGS:NBIX |
12,86 B | 14,30% | 4/6 | 22,36% | 33,96% | 36,97% | DOWN |
